This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
Cogent Biosciences, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $34.96
+13% in 7d after detection
Post-detection moves
1h
—
1d
-0.4%
3d
+3.9%
7d
+13%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS